A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF).

Project: Research

Project Details

StatusFinished
Effective start/end date3/03/22 → 31/12/24

Keywords

  • Respiratory medicine
  • Cystic fibrosis
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)